CD8A and neoplasm: Given the critical role of dendritic cell-mediated cross-presentation in the priming and activating naïve tumor-specific CD8+ T cells, we proceeded to evaluate the impact of LiSmore on antigen presentation, as well as the activation and proliferation of CD8+ T cells.